Back to search

University of Sheffield

Investigation of siRNA as a Treatment for Cushing’s Disease

Abstract

dc:description.abstract

Cushing's disease results from a pituitary corticotroph adenoma that secretes adrenocorticotrophic hormone (ACTH). High levels of ACTH stimulate the synthesis of excess cortisol from the adrenals, the effects of which include hypertension, diabetes, depression, and weight gain. If left untreated, Cushing's disease carries a 50% five-year mortality rate. At present, there is no suitable medical therapeutic and transsphenoidal surgery, which is the first line treatment, has a high rate of recurrence. RNA-interference is a cellular mechanism that enables gene silencing at the level of mRNA. It can also be used to reduce gene expression by employing small interfering (si)RNAs that target the specific gene of interest. The proopiomelanocortin (POMC) peptide is encoded by the POMC gene and is processed to release ACTH as well as other hormones.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Alzahrani, Ahmed
Advisors dc:contributor.advisor
  • Kemp, Elizabeth Helen
  • D Newell-Price, John

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.837152

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Alzahrani, Ahmed. Investigation of siRNA as a Treatment for Cushing’s Disease. doctoral thesis, University of Sheffield, 2021.